HomeCompareMGROF vs MRK

MGROF vs MRK: Dividend Comparison 2026

MGROF yields 500.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MGROF wins by $61399.47M in total portfolio value
10 years
MGROF
MGROF
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full MGROF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MGROF vs MRK

📍 MGROF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMGROFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MGROF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MGROF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MGROF
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MGROF beats the other by $37,454,033,409.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MGROF + MRK for your $10,000?

MGROF: 50%MRK: 50%
100% MRK50/50100% MGROF
Portfolio after 10yr
$30699.79M
Annual income
$22,031,794,156.92/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MGROF
No analyst data
Altman Z
-3.2
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MGROF buys
0
MRK buys
0
No recent congressional trades found for MGROF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMGROFMRK
Forward yield500.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$61399.52M$56.8K
Annual income after 10y$44,063,578,515.70$9,798.13
Total dividends collected$59892.67M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MGROF vs MRK ($10,000, DRIP)

YearMGROF PortfolioMGROF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$60,700$50,000.00$11,206$366.19+$49.5KMGROF
2$348,594$283,644.86$12,650$502.35+$335.9KMGROF
3$1,895,372$1,522,376.89$14,407$694.19+$1.88MMGROF
4$9,763,990$7,735,942.00$16,585$967.82+$9.75MMGROF
5$47,691,977$37,244,507.54$19,342$1,363.89+$47.67MMGROF
6$221,049,019$170,018,603.23$22,913$1,947.19+$221.03MMGROF
7$972,993,924$736,471,474.07$27,662$2,823.89+$972.97MMGROF
8$4,070,762,075$3,029,658,575.98$34,159$4,173.35+$4070.73MMGROF
9$16,201,818,371$11,846,102,950.68$43,337$6,308.80+$16201.78MMGROF
10$61,399,524,173$44,063,578,515.70$56,776$9,798.13+$61399.47MMGROF

MGROF vs MRK: Complete Analysis 2026

MGROFStock

MustGrow Biologics Corp., an agricultural biotech company, focuses om development and commercialization of natural biopesticide, biofumigants, and bioherbicides derived from mustard seed. It provides preplant soil biofumigation, a technology to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and other crops. The company is also developing bioherbicide to treat unwanted plant growth for use in organic agriculture, home, and garden markets, as well as agriculture markets; and postharvest food preservation, an application in sprout, disease, and pathogen treatment for storage and food preservation markets. In addition, it focuses on providing CannaPM, an active ingredient to treat fungal soil diseases, as well as foliar diseases. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.

Full MGROF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MGROF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MGROF vs SCHDMGROF vs JEPIMGROF vs OMGROF vs KOMGROF vs MAINMGROF vs JNJMGROF vs ABBVMGROF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.